Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions — Shirley Wang (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions
Shared by
John P A Ioannidis
Stanford University
Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions
Article
2022
en
Authors
+68 more
SW
Shirley Wang
SS
Sushama Kattinakere Sreedhara
SS
Sebastian Schneeweiß
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2018
Should real-world evidence be incorporated into regulatory approvals?
Ernest Spitzer
,
Christopher P. Cannon
,
Patrick W. Serruys
Expert Opinion on Drug Safety
Article
2024
Applying Clinical Risk Scores in Real-World Practice
Geoffrey D. Barnes
,
Professor Gregory Lip
Article
2025
Disease course of dMMR endometrial cancer in real-world clinical practice.
Michalis Liontos
,
Anna Svarna
,
Aikaterni Aravantinou Fatorou
,
Athanasios Michas
,
N Dedes
,
Αngeliki Andrikopoulou
,
Alkistis Papatheodoridi
,
Αριστέα-Μαρία Παπανώτα
,
Joanna Collaros
,
Eleni Zografos
,
Μαρία Καπαρέλου
,
Flora Zagouri
,
Meletios A Dimopoulos
Article
2019
Safety of direct oral anticoagulants in real–world clinical practice: translating the trials to everyday clinical management
Ameenathul M. Fawzy
,
Wangyang Yang
,
Professor Gregory Lip
Article
2025
Systematic Review of Efficacy and Safety of Avacopan in Real-World Clinical Practice
Ilay Berke
,
Felix Keller
,
Clemens Untersulzner
,
Jae Il Shin
,
Peong Gang Park
,
Sarah Soyeon Oh
,
Jasper Callemeyn
,
Andreas Kronbichler
Discussion(0)
No comments yet. Be the first to comment.